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Abstract
The availability of medical equipment contributes significantly to the stability and
sustainability of health care systems. However, in some countries, especially the
developing ones, medical equipment availability is a major issue that remains un-
solved. Hence, this paper explores the root causes of the issue, reviews existing
solution approaches and suggests remanufacturing as a sustainable option. An exten-
sive review was first conducted to uncover key factors contributing to the poor
availability of medical equipment in developing countries. The Decision-Making
Trial and Evaluation Laboratory (DEMATEL) method was then used to measure the
prominence degrees of the key factors and characterise these factors with an aim to
differentiate those that are net drivers from those that are driven. Subsequently, factors
that can be addressed by remanufacturing were identified, to determine the potential
contribution of remanufacturing in addressing the poor medical equipment availabil-
ity issue. The result shows that remanufacturing can potentially address at least five of
the key factors which account for a cumulative total prominence of 43.5%.
Remanufacturing is thus, a viable strategy for improving medical equipment avail-
ability in developing countries. In addition to remanufacturing, other recommenda-
tions were also proposed to help address the issue.
Keywords Medical equipment .Remanufacturing .DEMATEL .Medical equipment availability
Introduction
Medical equipment are reusable medical devices that are durable, expensive, complex,
maintainable/repairable and which often require user training, calibration and
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decommissioning are referred to as medical equipment [48]. According to the World Health
Organisation [61], medical equipment do not include implantable, disposable or single use
devices. Their availability is associated with improved patient outcomes. Thus, healthcare
administrators seek innovative means of optimising its supply [56], However, providing access
to medical equipment can be difficult for some countries such as those facing extreme
austerity; among which developing countries are typical examples. Remanufacturing seems
to be a potential solution but has not been previously considered. Remanufacturing is the
process of restoring a used product to at least, its original equipment manufacturer’s perfor-
mance specification from the customer’s perspective and giving the resultant product a
warranty that is at least equal to that of newly manufactured equivalent product [64]. This
study estimates the potential impact of remanufacturing in addressing medical equipment
availability issues in developing countries.
Developing countries are those categorised by the World Bank as low and middle-
income earners [4]. For many of these countries, it is difficult to access medical
equipment necessary for healthcare even though they are indispensable to the diagnosis,
prevention, monitoring and treatment of disease and injury. This challenge is important,
considering that about 85% of the world’s population reside in developing countries
which account for just 15% of global market for medical equipment [6, 60]. Conse-
quently, the healthcare quality in developing countries is poor, resulting in high
mortality rates over conditions that would otherwise be easy to treat and manage if
the right equipment were available. For instance, over the globe, 2.6 million neonatal
deaths, 2.8 million still births and over 287,000 maternal deaths were recorded in 2009.
About 99% of these deaths occurred in developing countries often due to lack of
complex medical equipment such as diagnosis equipment which cause delayed advising
and referral [16]. Previous studies [1, 8, 32, 45, 58, 70] comment on the factors
responsible for the problem without aiming to explore their interrelationships. They
propose solutions from perspectives that are often either isolated or not based on
holistic approach. By analysing the factors, taking account of interdependencies among
them; this paper aims to determine the applicability of remanufacturing in addressing
the problem of poor access to medical equipment.
Review of related literature
Current approaches to addressing poor availability of medical equipment
Due to the grave consequences of poor access to medical devices in developing countries,
several efforts have been implemented to address the problem. These include the following:
• Medical equipment donation from government and non-governmental organisations
abroad [2, 17, 34, 43, 59, 61, 67].
• Design of low cost medical equipment for developing countries [27, 36, 37, 47].
• Use of imported refurbished medical devices [17].
• Promotion of local production [4, 65].
Local production of medical equipment is desirable since it can potentially make
medical equipment more available and sustainable in any given setting. However, it is
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not an easy alternative for developing countries due to the advanced technological
requirements of modern manufacturing [23] which are often unavailable in many
developing countries. The challenges associated with the other approaches are
discussed in the following sections.
Challenges of medical equipment donations to developing countries
Medical equipment donations usually come from developed countries’ governments,
charity organisations, hospitals, health clinics and educational organisations [2, 62].
Donations may be motivated by genuine intentions. However, some donors may have
some indirect financial motivation. For instance, a study of medical equipment
donations from Canada found that financial incentives from manufacturers of medical
equipment to hospitals that dispose of their used equipment themselves may motivate
medical equipment donations [2].
Major destinations of medical equipment from international donors include Malawi, India,
Pakistan, Somalia, Sri-Lanka, Nigeria, Philippines, Syria, Uganda, Cuba and Cameroun [17].
Developing countries’ hospitals usually engage the services of non-profit or charity organisa-
tions to source for potential donors in order to avoid the legal rigours associated with medical
equipment donations especially due to the restricted trans-border movement [2].
Reports about the utility of donated equipment suggest that only few of them actually
become useful to the recipients [43, 59, 61]. In view of this, the World health organisation
consistently makes efforts to rationalise medical equipment donation so that recipient countries
can derive utility from them. The first draft guideline towards this objective became available
in 2000 and was subsequently updated in 2011 [61]. The Tropical Health Education Trust
(THET) also has a publication titled: “Toolkit for medical equipment donations to low resource
settings” aimed at improving the donation process especially for the poorest countries that rely
almost entirely on it.
The three government agencies in the recipient country that are often involved in receiving
donated equipment are the Ministry of Health, Ministry of Commerce and Customs [17] . But
in practice, only the Customs and Commerce get involved for tax clarifications; the use of
many donated medical equipment therefore, commences before proper acceptance or quality
assurance testing. Thus, donated equipment are not usually subjected to post donation
inspection and certification of quality [69]. This results in equipment which often do not pass
quality tests. A study of a Tanzanian hospital staff’s perceptions of donated medical equipment
shows that 78% of participants were discontented with the equipment. The most important
reasons given by these discontented respondents are lack of technical support and specifica-
tions crucial to the use of the equipment [69].
If a donation solicitor decides to be careful to ensure that only the right equipment
are transferred to recipients, then the more complex equipment will usually not be
accepted due to lack of expertise needed to repair or maintain them [17]. This
consideration would subject the people in the recipient country to a limited supply
of the more sophisticated medical equipment needed in health care. This implies that
a sustainable solution to medical equipment availability in developing countries should
provide sustained access to the equipment through promotion of commercial activities
required to avail spare parts, accessories, consumables and technical support services.
Obviously, medical equipment donations fall short on these requirements. Consequent-
ly, medical equipment donation may only be a temporary measure.
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The downside of designing low cost medical equipment for developing countries
According to Eltringham and Neighbour [12, 13], claims that low cost medical equipment
designs can address the medical equipment availability issues in developing countries
raise several important questions. Firstly, the author notes that the so-called low-cost
equipment are in reality, subsidised since the cost of development which is usually in
the form of grant to the research institutions are often ignored. Secondly, the author
emphasises that the principle of low-cost design is usually based on the use of low-
quality components or improvising to make the final product’s price less than its equiv-
alent in the market. Limiting the functionality of an equipment in a bid to making it less
expensive may however, have moral and ethical implications.
Eltrinhham and Neighbour also observe that only a few of the so called low cost or
subsidised product designs become successfully developed eventually and these are
supplied to developing countries through non-commercial means [13]. Moreover, since
the institutions carrying out the design and manufacture of the devices do not usually have
a commercial base or route to the market, the authors note that they are likely to go out of
business as soon as the funding ceases, leaving users of the equipment without technical
support necessary for their sustained utilisation. Thus, it is vital to supply medical
equipment to developing countries through indigenous resellers, agents and suppliers as
this approach will enhance commercial activities and sustainability by providing local skill
sets and spare parts for maintenance.
Direct reuse of medical equipment or reuse of repaired/ refurbished equipment
Medical equipment value chain should not terminate at post sales services or end of life which
marks the point where the products are discarded due to technological obsolescence, deteri-
oration or change in consumer preferences. It is conceivable that medical devices that reach
their end of life (EOL) for instance, due to change in user’s preference (such as decision to opt
for a more innovative technology) would have the majority of their components good enough
to extend the product’s life or even to sustain it through another lifecycle. Instead of disposing
products, at this stage, an EOL strategy may be applied to extend or renew their utility. EOL
strategies refer to the different ways of recovering products with differing levels of reuse.
These strategies mitigate environmental impacts and add economic benefits to product dis-
posal [19, 49] and include the following [46]:
& Direct reuse.
& Repair.
& Use of reprocessed medical devices. Reprocessed devices include the following [41]:
& Refurbished devices
& Remanufactured / fully refurbished devices (Term used in Europe) devices
EOL processes vary in terms of quality as well as price of the resultant products.
Repair involves reworking or replacing only damaged components without aiming to
restore the product to its original specification [22]. In refurbishment, the used product
is reprocessed such that its performance is returned to limits considered acceptable for
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reuse [41]. However, remanufacturing yields a product which at least, equals an
equivalent new one in terms of performance specifications and warranty. Both a whole
product and sub-assemblies can be remanufactured [22]. In order to determine the
applicability as well as the potential impact of implementing medical equipment
remanufacturing, it is necessary to first explore the factors responsible for the poor
availability of medical equipment.
Root causes of poor availability of medical device in developing countries
The poor availability of medical equipment in developing countries is caused by several key
factors and has been widely studied [1, 18, 30, 43, 57, 68]. In this section, these factors are
presented as identified from the literature.
Corruption
According to Bouchard [8], corruption in healthcare organisation contributes significantly to the
problem. The authors found that corruption within the health care industry usually takes the form of
inflation of equipment prices, purchase of lower quality equipment and products as well as lowering
of care quality which ultimately resist the necessary response to alleviating health care challenges.
Lack of funds
Lack of funds is an important factor causing the poor availability of medical devices in
developing countries. Many developing countries do not have sufficient funds to acquire
necessary equipment [32, 39, 45]. The people are also unable to pay for expensive lifesaving
procedures [11]. Thus, poverty, illness and disability are related [11].
Lack of robust regulation, HTA and HTM
The World Health Organisation recognises the need for poorer countries to have stronger
regulations as well as health technology assessment and management policies in place to
optimise medical equipment procurement and use [62]. However, this is often not the case [10,
38, 43, 57]. Health Technology Assessment (HTA), Health Technology Management (HTM)
and Regulatory units should collaborate to achieve their objectives. HTA supports evidence
based decision-making preceding the acquisition of new technologies [62]. This is necessary to
ensure that proposed new technologies are those that will be effective, appropriate and
implementable towards advancing health care quality.
HTM also known as clinical engineering carries out planning, needs-assessment, selection,
procurement, inventory, installation and maintenance of medical equipment as well as training
and decommissioning [28, 62] The tasks associated with each element include technical advice,
planning and costing, supply chain, disposal and record keeping. A study finds that available
medical equipment in developing countries can be doubled just by implementing HTM [43].
Inappropriateness of available equipment
The implication of weak or absent HTA, HTM and regulation include lack of
standards and abundance of sub-standard equipment or those that do not contribute
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to healthcare. Thus, much of the medical equipment in developing countries are not
useful in addressing prevailing disease burden. This is because some medical equip-
ment commonly found in developing countries are those that are not designed for the
prevailing needs [18, 57]. Because medical equipment procurement is largely uncoor-
dinated, products from a wide variety of manufacturers are available. Under such
circumstance, it becomes difficult for the technicians to gain the proficiency necessary
to maintain the available equipment varieties. This ultimately challenges the sustain-
ability of medical equipment in developing countries [7].
Lack of skilled workers
According to Malkin [30], technicians were found to have inadequate skills and users have
poor understanding of how to use medical equipment. Consequently, equipment damage
becomes frequent leading to the disrepair states of many medical equipment [43]. Due to lack
of skilled workers, functional equipment may also be classified as damaged. For instance, a
study of 1704 documented failed medical equipment finds that 25% of the equipment
classified as failed were actually in good working order [31].
Lack of spare parts
Equipment may be unavailable in developing countries because of lack of spare parts [5, 55].
This causes both delay in carrying out procedures and an upward push in the total cost of
ownership of medical equipment [29]. Also, many of the available medical equipment are
obsolete [38] and as a result, their production by their manufacturers may have been
discontinued. In such cases, there would be only a minimal chance of successfully repairing
the equipment due to lack of access to spare parts.
Lack of economic model
Hospitals in developing countries often do not aim to minimise costs by for instance, making
use of a technology only when it is absolutely necessary or minimising the duration of hospital
stay [26, 43]. Malkin also notes that the poor availability of medical equipment in developing
countries may not be so much about poverty since there are already medical equipment whose
maintainability are usually not sustained [33] but due to lack of economic models.
Poor infrastructure
Other causes of poor availability of medical equipment in developing countries include lack of
infrastructure such as electricity and oxygen [14, 45, 47]. For instance, the use of modern
technology usually requires stable and reliable supply of electricity as well as electronic
devices and the internet; these are not available in many developing countries [17].
Unreliable supply chain communication
Most medical equipment are manufactured outside developing countries; necessitating
well-coordinated supply chains to acquire consumables and spare parts. This is usually
not available [35, 47, 69].
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Workers’ attitude
In some cases, clinical staff may refuse to use an equipment if they consider them difficult or
inconvenient and may even declare them damaged [45].
The causes of poor medical equipment availability in developing countries are
numerous as has been shown. These are summarised in Table 1. Addressing these
factors therefore requires understanding their respective degrees of prominence and the
causal relationships existing among them. This will aid in effectively focusing efforts
to mitigate them. To achieve this, the Decision-Making Trial and Evaluation Labora-
tory (DEMATEL) technique is adopted in this study to determine the weight of each
factor by considering its impact on the other factors. Section 3 provides more
information about the technique.
Methodology
This paper first reviews related literature to identify the root causes of poor medical
equipment availability in developing countries as well as current approaches aimed at
addressing them. The factors identified from the literature were validated by senior
health care workers selected from secondary and tertiary hospitals in Nigeria. The
validation was done to confirm that the findings agreed with what was obtainable on
ground. The DEMATEL technique was then used to analyse the identified root causes
to evaluate their impacts and causal relationship existing among them. The
DEMATEL analysis technique was chosen since it can effectively demonstrate mutual
influences, both direct and indirect and is therefore suitable in analysing complex
cause and effect problems such as the one encountered in this study. Other multi-
criteria decision methods such as Analytic Hierarchy Process and Technique for order
performance by similarity to ideal performance (TOPSIS) fall short in these respects.
Unlike these other techniques, DEMATEL also allows aggregated group decision
making which can yield more valid results by including inputs from more than one
decision maker in the analysis [51].
The relative total prominence of the root causes addressed by remanufacturing was
then expressed as a percentage of the overall total prominence of all the factors to
determine the potential impact of medical equipment in addressing the root issue of
poor medical equipment availability.
The DEMATEL method
The DEMATEL is a multi-criteria decision-making technique that was firstly applied in the
Science and Human Affairs Programme of the Batelle Memorial Institute to analyse compli-
cated interrelationships [66]. It is an efficient technique for exploring the interrelationships
among alternative criteria or factors. Apart from its ability to produce a model of interrela-
tionships, DEMATEL can also measure the impact of each factor on the others and can be used
to prioritise factors according to relative impacts or degrees of prominence. It also supports
group decision making and can be applied to relatively large number of factors to help decision
makers in selecting the best strategic alternatives following three key stages as summarised by
Ahmet et al. [3]:
Journal of Remanufacturing
Table 1 Summary of factors responsible for the poor availability of medical equipment in developing countries
S/N Factors Details References
F1 Corruption Corruption often takes the form of
embezzlement of funds allocated to
the purchase of medical equipment or
stealing of – equipment; often
possible due to the peculiar nature
of health care industry.
[8]
F2 Attitude/Perception Staff may refuse to use medical devices
if they consider them difficult to use
or may incorrectly declare an
equipment damaged.
[45]
F3 Lack of funds to access
and/or to fund the purchase
of equipment
Governments in many developing
countries often cannot afford the cost
of state-of-the-art equipment. The
people are also poor and may not be
able to pay for procedures involving
expensive medical equipment.
[11, 30, 39, 45].
F4 Lack of infrastructure such as
electricity, water supply,
oxygen.
Poor infrastructure such as reliable
electricity, water supply, roads,
oxygen.
[14, 17, 45, 47]
F5 Absence of HTM and HTA The main problems faced regarding
medical equipment include lack of or
poor health technology management
policy which results in poor planning
for procurement and sustenance. Lack
of regulation affects the effectiveness,
durability and consequently,
the effective lifetime
of medical equipment.
[10, 38, 43, 57, 62]
F6 Weak or absent regulation.
F7 Lack of skilled workers Trained experts for use and maintenance
of medical equipment are usually not
available and training is poor
[5, 31, 32, 43, 55]
F8 Lack of spare parts
and consumables
Damage to the equipment requiring
spare parts cannot be rectified due to
the unavailability of the spare parts in
the local market.
[5, 29, 33, 43, 55]
F9 Lack of clear economic model Developing countries’ hospitals do not
often aim to minimise costs whereas
there is need to always conduct
economic evaluation of medical
devices to demonstrate
their cost effectiveness.
[26, 33, 43]
F10 Inappropriateness
of available equipment
Available equipment are often
inappropriate for the needs of the
developing countries. They may be
for treatment of diseases that are not
common in the country or are not
designed to be compatible with
realities on ground
[18, 31, 33]
F11 Unreliable or ineffective supply
chain communication
Medical equipment are mostly
manufactured outside of developing
countries necessitating supply chain
frameworks which are sadly
inexistent or ineffective. Biomedical
technologists and engineers are also
not part of the procurement process
[35, 47, 69]
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Stage 1. Participants in the study were selected as summarised in Table 2, to evaluate in a pairwise
manner, the direct impact of each factor Fi on Fj. Each respondent was first introduced to the
identified factors as well as the pattern for conducting the pairwise comparisons. The impact is
assessed using integers ranging from 0 to 4; with 0 representing no influence, 1 representing very
low influence, 2 representing low influence, 3 representing high influence and 4 representing very
high influence. The magnitude of each factor’s influence is indicated by the notation: aij which is
the degree of influence that factor i has on factor j according to the assessment of each respondent.
Given that there are n factors (F1,F2,…Fn) in the resultant n × n comparison matrix for each
expert, then the terms i = j = 0 representing the diagonal terms will equal zero since a factor
would have no impact on itself. Each respondent thus produces the matrix:
Ab ¼ abij
 
;where b ¼ 1; 2;…M refer to individual respondents ð1Þ
Stage 2: To aggregate the views of the respondents, the average of the direct relation matrix is
evaluated as follows:
xij ¼ 1M ∑
M
b¼1aij ð2Þ
Stage 3: The average direct matrix [xij] is normalised to give T, according to the
following relation:
T ¼ X  C ð3Þ
Where X = [xij] and C = min½ 1max∑ni¼1xij,
1
max∑nj¼1xij
]
The elements of the normalised matrix T are in the range 0 to 1.
Stage 4: Finally, the total relation matrix U is calculated using the following equation:
U ¼ T I−Tð Þ−1 Where I is the identity matrix ð4Þ
In the matrix U, ri is the ith row sum in the matrix U and signifies the sum of direct and
indirect effects emanating from Fi to other factors. Similarly, cj is the jth column sum in the
same matrix and represents the sum of direct and indirect effects impacting on factor Fj
from other factors. Hence,
R ¼ ri½ nx1 ¼ ∑nj¼1uij
h i
nx1
C ¼ c j
 
1xn ¼ ∑nj¼1uij
h i
1xn
ð5Þ
Table 2 Characteristics of respondents for the pairwise comparison
Respondent Type of Organisation Profession Number of years
of experience
1 State teaching hospital Biomedical Engineer 9
2 Federal teaching hospital Senior Radiographer 8
3 State university/teaching hospital Biomedical Engineering Lecturer 10
4 Mission hospital Medical Doctor 7
5 State Teaching Hospital Biomedical Engineer 9
6 Federal Teaching hospital Biomedical Engineer 22
7 Private hospital Medical Doctor 7
8 Independent medical equipment
designer and repairer
Biomedical
Engineering Technologist
23
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Characteristics of study participants
The participants in this study were selected based on their experience in their respective
positions and good understanding of medical equipment related issues in their organisations.
They come from private, secondary and tertiary hospitals where medical equipment need is
extensive. One of the participants is also, actively involved in design and maintenance of
medical equipment for local use. Hence, the participants’ views are valid and capable of
representing the reality regarding factors affecting medical equipment availability. In this
study, inputs from 8 participants were used. Compared to Shao and Mier [50] which only
included three participants and et al. [3] which used inputs from only 5 participants, the
number of participants in this study can be assumed to be substantial.
Results
Given that the vectors [ri]n × 1and [cj]1 × n in the matrix U represent the sum of the columns and
sum of the rows of the total direct relation matrix respectively, then rirepresent the direct and
indirect impacts of factor Fi on other factors. Similarly, cj represents the direct and indirect
impacts of other factors on factor Fj. The sum (R +C) otherwise referred to as the Prominence
expresses the total effects caused and received by a factor. On the other hand, the difference
(R –C) called the Relation represents its net influence on the others. If the value (R + C) >
0,then the factor is a driving factor, otherwise the factor would be a driven factor if (R −C) < 0.
A threshold value is computed from the total relation matrix U which represents the minimum
significant influence to be considered individually. The threshold may be calculated following
Shao and Mier’s technique by summing the mean of the total relation matrix and its standard
deviation as follows:
Mean Uð Þ þ σ Uð Þ ð6Þ
Stronger causal relationships may also be obtained by instead, adding two standard deviations
of the total relation matrix; that is:
Mean Uð Þ þ 2σ Uð Þ: ð7Þ
Table 3 summarises the values that are up to these thresholds. Values marked with asterisk are
those exceeding the second threshold obtained by adding two times the standard deviations of
the total relation matrix to its mean.
Degrees of prominence of factors
The degrees of prominence and characteristics of each factor are as summarised in Table 4. It is
based on the (R + C) values and is as follows:
F1 > F9 > F3 > F5 > F6 > F8 > F7 > F2 > F4 > F10 > F11:
Thus, corruption (F1) is the most prominent reason for shortage of medical equipment while
unreliable supply chain communication (F11) is the least. In addition, corruption (F1), lack of
clear economic model (F9), lack of funds (F3), absence of HTA and HTM policies (F5), Weak or
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absent regulation (F6), lack of infrastructure (F4) and unreliable or ineffective supply chain and
communication involving recipients (F11) are net drivers. On the other hand, the driven factors
include unavailability of spare parts and consumables (F8), lack of trained or skilled maintenance
staff (F7), workers’ attitudes and perception (F2) and equipment inappropriate for the needs (F10)
are net influenced factors responsible for the poor availability of medical equipment.
Table 3 also shows that corruption is driven by lack of funds (F3), absence of HTA and
HTM (F5) and weak or absent medical device regulation (F6). Similarly, workers’ perception
and attitude (F2) is driven by corruption (F1), lack of funds (F3), lack of infrastructure (F4),
absence of HTA and HTM (F5), weak or absent medical device regulation (F6), lack of trained
or skilled maintenance staff (F7) and lack of clear economic model (F9). Corruption (F1) is the
main cause of lack of funds (F3) which is at the same time, responsible for lack of infrastruc-
ture (F4). Corruption (F1) is also the most important factor responsible for the weak or absent
medical device regulation (F6). Lack of trained maintenance staff (F7) and unavailability of
spares and consumables (F8) are both driven by corruption (F1), lack of funds (F3), absence of
HTA and HTM (F5), weak or absent medical device regulation (F6) as well as lack of clear
economic models (F9). However, lack of clear economic models (F9) is caused by corruption
(F1) and absence of HTA and HTM (F5). Finally, equipment are inappropriate for healthcare
needs (F10) because of corruption (F1), lack of funds (F3) and absence of HTA and HTM (F5).
Potential impact of remanufacturing as a sustainable solution to the problem
Remanufacturing can contribute towards addressing some of the factors responsible for
the poor availability of medical equipment. Specifically, remanufacturing can provide
Table 4 Potential contribution of remanufacturing in increasing availability of medical equipment
remanufacturing
Factor Total
prominence
(R +C)
Potential to be
addressed
by remanufacturing
References
Corruption 8.1743
Attitude/perception 7.3741
Lack of funds to access
and/or to fund the purchase
of equipment
7.9821 √ Remanufacturing can provide low
cost alternatives [9, 21, 22, 25, 41]
Lack of infrastructure
such as electricity, water
supply, oxygen
7.12
Absence of HTM and HTA 7.7461
Weak or absent medical
device regulation
7.6975
Lack of trained or skilled
maintenance staff
7.3959 √ Remanufacturing develops
skills [21, 22, 44]
Unavailability of spare parts
and consumables
7.5289 √ Spare parts provision which enables
prolonged use of products and
components even after their
production has ceased [21, 49]
Lack of clear economic model 7.9898
Equipment are inappropriate for
the needs of the people
6.4873 √ By engaging local workers, the issue
of needs communication along
supply chains will be
addressed [53, 54]
Unreliable or ineffective supply
chain communication
6.0966 √
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affordable quality medical equipment since in general, remanufactured products are sold
at much lower price than equivalent new ones [22, 25, 52]. The price of remanufactured
products average at 60% of those of equivalent new products [20, 41]. This lower price
achievable since only about 15% of the energy required to manufacture equivalent new
products is utilised in remanufacturing [9, 22]. Moreover, remanufacturing has the
potential to create an industrial base for developing countries [44] through associated
workforce training, new equipment procurement and technology transfer. This is because
remanufacturing is labour intensive [22, 44] and currently requires less technological
sophistication than conventional manufacturing. Thus, it can potentially promote com-
mercial activity in the medical device sector and contribute to skills development in
medical equipment technology. Thus, medical equipment remanufacturing can help to
develop skilled manpower needed for the maintenance of medical equipment.
Another key feature of remanufacturing is its incorporation with product sales service (PSS)
which involves a greater focus on the product’s functionality rather than mere products [15, 63].
Through this strategy, remanufacturing can provide increased access to spare parts [49]. This is
achievable since both whole products and sub-assembles can be remanufactured [22]. Medical
equipment remanufacturing therefore, also has the potential to increase access to functional
medical equipment spare parts and can help address the challenge of unavailability of spare parts.
The success of remanufacturing depends largely on communication among supply chain
players including users [40, 53]. Medical equipment remanufacturing can help bridge such
communication gap among users through its emphasis on PSS which is aimed at optimising
the utility that products offer their users. Further, by implementing remanufacturing, imported
medical equipment can be adapted to developing country needs and specifications in a manner
that will ensure that the product would serve appropriately.
The potential contribution of medical equipment remanufacturing in addressing the poor
availability of medical equipment may be estimated as a percentage of the overall total
prominence, as follows:
100 ∑
m
i¼1pi
∑nj¼1pj
¼ ∑
k
i¼1ri þ ci
∑ljri þ ci
; ð8Þ
k = 5 = number of factors potentially addressed by remanufacturing as shown in Table 4
l ¼ 11 ¼ total number of factors
Pi ¼ total prominence of the 5 factors potentially addressed by remanufacturing Table 4ð Þ
P j ¼ total prominence of all 11 factors af fecting medical equipment availability
Thus, the potential contribution of medical equipment remanufacturing in addressing
medical equipment availability is approximately 43.5%.
Remanufacturing as a potential sustainable solution for increasing
medical equipment availability in developing countries
According to Pearce [42], the following types of customers are likely to be interested in
remanufactured products:
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• Those that need to retain a specific product for their processes.
• Users that want to avoid the rigour of the recertification or re-approval process preceding
product purchasing.
• Those that make relatively less use of new equipment and are price sensitive.
• Those that would like to continue the use of products whose OEMs no longer produce
• Customers that may only want to extend the service life of their used equipment.
• Customers that are environmentally conscious.
The shortage of basic life-saving medical equipment in developing countries suggests that
health care institutions would wish to retain their medical equipment for long time, even after
OEMs have discontinued their production. Moreover, developing countries are not accus-
tomed to using new and state of the equipment [38] and are price sensitive due to lack of funds.
It therefore appears highly likely that health care systems in developing countries will benefit
from medical equipment remanufacturing.
Recommendations
The results of this study indicate that the absence of HTM and HTA contribute to the
unavailability of skilled maintenance staff, unavailability of spare parts and consumables, lack
of economic model as well as acquisition of equipment that are inappropriate for health care
needs. HTA and HTM play key roles in healthcare; yet they are almost weak or absent in many
developing countries. While HTA ensures that technologies are appropriate towards addressing
prevailing healthcare challenges, HTM guarantees successful utilisation of medical equipment.
Implementing HTA and HTM thus, includes gathering reliable information about proposed
new equipment; planning and selecting technologies based on prevailing needs, making
resources available to ensure the sustainability of equipment, purchasing the right models of
equipment and installing them correctly as well as making plans for decommissioning,
disposal and replacement of unsafe or obsolete equipment. Thus, HTA and HTM policies
are to be motivated by the type of health care an organisation intends to provide and thus;
contributes to the achievement of standardisation, improved maintenance practice as well as
resource optimisation [28]. Such standardisation facilitates the development of maintenance
capability and improved access to spare parts. HTM policies ensure that budgetary provision is
made for the maintenance of technologies along their life cycles and thus, incorporates some
economic consideration regarding sourcing of funds. Economic models may include limiting
the length of hospital stay and ensuring that expensive procedures and techniques are reserved
as last options. Weak or absent regulation also contributes to the lack of skilled maintenance
staff as well as lack of spare parts and consumables. According to one of the study participants,
“Medical equipment come into the country from many sources without passing through
standard pre-entry evaluation. The safety, effectiveness and durability of equipment are
thus, not guaranteed and so, they break down too frequently.”
When equipment, especially the second-hand ones are imported without the necessary
regulatory coordination and control, the risk of not being able to source spare parts
emanates. This is mostly the case when the manufacturers have discontinued the produc-
tion of spare parts [24]. This study finds that corruption contributes to the inefficiency of
medical equipment regulation. One of the respondents to the study observed that policies
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and frameworks are usually available but not implemented since those responsible are
often easily compromised. Governments and relevant organisations may take decisive
action against corrupt acts which hinder regulatory dispensation as well as formulate and
implement robust HTA and HTM policies.
Conclusions
The analysis performed in this research shows that corruption is the most important factor,
followed by lack of clear economic model and then lack of funds. Current approaches towards
addressing the availability issue has proven to be unsustainable. This paper however, demon-
strates that remanufacturing is potentially capable of contributing towards solving five of the
root causes of the problem; accounting for 43.5% of the overall total prominence of the
identified root causes. In addition to remanufacturing, other recommendations including taking
decisive action against corruption in all its forms, formulation and implementation of robust
HTA and HTM as well as regulatory policies are suggested to help address the problem.
This study has some obvious limitations in its estimation of the potential impact of
medical equipment remanufacturing. First, it relies on the experience of just 8
participants. It has also not accounted for the vagueness in human judgement. Other
potential areas of future work in the area include developing decision support tools
for medical equipment for remanufacturing and conducting case studies to assess the
feasibility of remanufacturing individual medical equipment.
Appendix: Pairwise comparison matrices
A1 =
0 4 4 3 4 2 3 3 3 3 3
4 0 1 3 1 2 2 1 1 0 1
4 4 0 3 3 1 2 3 0 3 2
4 4 4 0 2 1 1 3 2 1 0
4 4 4 3 0 3 3 1 1 4 3
4 4 2 4 3 0 1 3 1 4 2
3 4 4 4 1 2 0 4 1 2 1
3 4 4 4 1 1 3 0 3 1 1
2 2 3 3 1 1 2 3 0 3 2
2 1 2 4 1 4 1 3 3 0 1
2 1 4 3 1 4 3 4 3 4 0
2
66666666666666664
3
77777777777777775
A2 =
0 4 4 4 3 4 4 4 3 4 3
0 0 1 1 0 3 3 0 1 0 2
0 0 0 4 2 2 2 4 1 2 0
0 3 0 0 0 3 0 0 1 0 1
4 3 2 2 0 4 2 0 4 0 1
4 4 2 2 4 0 3 4 3 0 1
0 3 0 2 0 0 0 0 3 0 1
0 3 0 0 0 0 0 0 3 0 2
0 4 3 2 3 4 4 3 0 0 2
1 3 0 0 0 0 0 0 0 0 1
0 1 0 0 0 0 0 0 1 0 0
2
66666666666666664
3
77777777777777775
A3 =
0 3 3 3 2 3 2 3 3 2 3
3 0 2 2 2 3 3 2 3 3 2
3 4 0 2 2 2 2 3 3 2 2
3 3 0 0 2 3 2 2 3 2 2
0 3 0 1 0 3 2 3 2 3 2
3 2 2 0 0 0 3 2 3 3 3
3 2 0 0 0 0 0 3 3 2 2
0 3 1 0 0 0 0 0 3 3 2
0 3 3 3 3 0 3 3 0 4 3
0 3 0 0 0 0 0 0 0 0 3
0 2 0 0 0 0 0 3 3 0 0
2
66666666666666664
3
77777777777777775
A4 =
0 3 2 2 4 4 3 0 3 1 1
3 0 2 3 2 4 1 0 1 1 1
3 3 0 1 3 3 1 3 3 1 1
1 2 2 0 1 3 0 1 3 3 0
2 3 3 3 0 2 3 3 3 2 0
4 2 2 1 4 0 1 1 3 3 3
3 3 3 1 1 3 0 2 3 3 0
1 2 2 2 3 1 2 0 2 2 3
3 3 1 0 1 2 3 3 0 0 1
1 1 0 1 0 1 0 0 3 0 0
2 1 0 0 3 2 0 3 2 3 0
2
66666666666666664
3
77777777777777775
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A5 =
0 4 3 0 3 3 0 2 2 3 0
1 0 3 3 4 3 2 2 1 0 0
3 1 0 4 3 3 3 4 0 3 1
4 3 0 0 3 3 3 3 0 3 3
3 1 3 3 0 0 3 3 4 3 0
3 1 3 3 4 0 3 3 3 2 2
4 3 2 1 0 0 0 3 0 2 0
3 2 3 0 0 0 3 0 0 4 0
2 2 3 1 3 3 2 3 0 3 1
3 4 3 4 0 1 2 4 3 0 0
1 1 0 4 0 3 0 4 1 4 0
2
66666666666666664
3
77777777777777775
A6 =
0 3 4 4 3 3 3 2 2 4 3
3 0 3 3 4 4 3 3 2 3 2
4 3 0 3 2 3 4 4 2 3 1
4 4 4 0 1 3 4 3 1 3 2
3 1 2 2 0 2 3 2 1 1 2
3 2 4 4 2 0 2 3 1 2 2
3 4 2 2 3 3 0 3 2 2 1
3 2 3 3 1 2 3 0 2 2 2
2 1 3 3 2 3 1 1 0 2 1
3 1 1 1 1 1 1 1 1 0 2
2 3 4 4 4 3 2 3 3 3 0
2
66666666666666664
3
77777777777777775
A7 =
0 2 2 3 2 2 2 3 2 1 1
1 0 1 2 3 4 3 3 1 1 1
1 4 0 3 1 2 3 1 2 2 3
4 3 4 0 2 2 3 1 2 1 1
1 2 1 3 0 4 4 4 1 4 3
3 1 1 1 1 0 1 1 1 3 1
1 2 1 1 1 1 0 1 2 1 1
1 3 1 1 1 2 1 0 2 2 1
1 1 3 2 3 3 3 1 0 3 2
1 2 1 1 1 1 2 2 2 0 2
1 1 1 1 1 1 4 2 2 4 0
2
66666666666666664
3
77777777777777775
A8 =
0 3 4 2 2 2 3 3 2 3 1
1 0 1 1 1 0 1 2 2 1 1
1 4 0 3 1 1 3 4 1 3 3
0 3 1 0 0 0 0 1 3 1 1
3 2 1 3 0 1 3 4 4 3 2
2 1 1 1 2 0 1 1 1 3 1
1 2 2 1 3 1 0 3 2 1 1
1 4 1 1 1 1 2 0 2 1 1
3 3 3 1 1 1 3 3 0 2 1
1 3 3 1 1 1 2 2 3 0 1
2 2 1 1 1 1 3 3 2 4 0
2
66666666666666664
3
77777777777777775
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